pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
NOVARTIS · news · pharmadog
← back to NOVARTIS
News mentioning NOVARTIS
367
stories
Apr 28, 26
STAT+: Pharmalittle: We’re reading about warnings over Trump’s MFN plan, Purdue Pharma sentencing, and more
stat
Apr 28, 26
Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spending
endpoints
Apr 24, 26
Avalyn plots $182M IPO; WHO prequalifies Novartis' malaria drug
endpoints
Apr 24, 26
Novartis pulls Pluvicto prostate cancer label expansion filing in the EU
endpoints
Apr 23, 26
Novartis' radioligand therapy Lutathera could soon face generic competition
endpoints
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Enlivex excises 60%; Eyepoint halves headcount
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series A
fiercebiotech
← prev
page 13 of 13
next →
